Savant Capital’s State Street Health Care Select Sector SPDR ETF XLV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.6M Buy
23,094
+14,966
+184% +$2.23M 0.01% 476
2026
Q1
$1.19M Buy
8,128
+2,441
+43% +$377K 0.01% 564
2025
Q4
$880K Sell
5,687
-1,508
-21% -$226K 0.01% 626
2025
Q3
$1M Sell
7,195
-21
-0.3% -$2.84K 0.01% 577
2025
Q2
$973K Buy
7,216
+935
+15% +$126K 0.01% 528
2025
Q1
$917K Sell
6,281
-1,548
-20% -$225K 0.01% 503
2024
Q4
$1.08M Buy
7,829
+4,119
+111% +$603K 0.01% 625
2024
Q3
$571K Sell
3,710
-45
-1% -$6.82K ﹤0.01% 814
2024
Q2
$547K Sell
3,755
-45
-1% -$6.46K 0.01% 760
2024
Q1
$561K Buy
3,800
+154
+4% +$22.1K 0.01% 699
2023
Q4
$497K Buy
3,646
+1,394
+62% +$181K 0.01% 566
2023
Q3
$290K Sell
2,252
-440
-16% -$58.4K ﹤0.01% 658
2023
Q2
$357K Buy
2,692
+545
+25% +$71.8K 0.01% 600
2023
Q1
$278K Buy
+2,147
New +$280K 0.01% 612

Other funds holding XLV

Savant Capital's XLV Position: Q2 2026 in Review

Savant Capital increased its State Street Health Care Select Sector SPDR ETF (XLV) stake by 184% in Q2 2026, buying an estimated $2.23M and bringing the position to 23,094 shares worth $3.6M. The position accounts for 0.01% of the portfolio, ranked #476.

Savant Capital first reported a position in XLV in Q1 2023 and has held it in 14 quarters since. 1,852 funds tracked by Wall St. Rank hold XLV as of Q2 2026.

  • Savant Capital held 23,094 shares of State Street Health Care Select Sector SPDR ETF worth $3.6M as of Q2 2026.
  • Savant Capital bought 14,966 State Street Health Care Select Sector SPDR ETF shares in Q2 2026, an estimated $2.23M.
  • State Street Health Care Select Sector SPDR ETF made up 0.01% of Savant Capital's portfolio in Q2 2026, its #476 holding.
  • Savant Capital first reported a position in State Street Health Care Select Sector SPDR ETF in Q1 2023 and has held it in 14 quarters since.
  • 1,852 funds tracked by Wall St. Rank held State Street Health Care Select Sector SPDR ETF as of Q2 2026.

Based on Savant Capital's 13F filing for Q2 2026, filed 10 Aug 2026.